v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:      
Net loss $ (4,674,901) $ (8,909,114) $ (8,639,502)
Changes in operating assets and liabilities:      
Prepaid expenses and other   (162,705) (233,531)
Research and development supplies   508,146 275,518
Accounts payable   (449,489) (143,484)
Other current liabilities   594,220 75,641
Net cash used in operating activities   (8,277,156) (8,025,661)
Cash flows from financing activities:      
Net proceeds from issuances of common stock   15,600,504 7,770,844
Net cash provided by financing activities   15,600,504 7,770,844
Net increase (decrease) in cash and cash equivalents   7,323,348 (254,817)
Cash and cash equivalents, beginning of period   7,830,855 1,601,660
Cash and cash equivalents, end of period 1,346,843 15,154,203 1,346,843
Supplemental disclosure of cash flow information      
Cash paid for income tax witholding   54,034 5,099
Restricted Stock Units (RSUs) [Member]      
Supplemental disclosure of non-cash investing and financing activities      
Issuance of common stock for ELOC commitment fee   141,723 98,604
Excluding ELOC Purchase Agreement [Member]      
Adjustments to reconcile net loss to net cash used in operating activities:      
Share-based compensation   141,786 639,697
The 2025 ELOC Facility [Member]      
Cash flows from financing activities:      
Net proceeds from issuances of common stock $ 870,000   870,000
Supplemental disclosure of non-cash investing and financing activities      
Issuance of common stock for ELOC commitment fee   $ 0 $ 365,553